tasly 151 million yuan holding world pharmaceutical industry

Our intern reporter Zimming tasly (600535, stock bar) bulletin, tasly and cooperation marketing will be respectively in cash by the six natural shareholders held by the world pharmaceutical industry 60% of the equity, of which the company contributed 151 million yuan, by the world of medicine 45% of the equity, the joint venture marketing capital 50.34 million Yuan,　　15% per cent of the world's pharmaceutical industry.　　According to the audit report, as at April 30, the world drug industry net assets of 86.8477 million yuan, 2012 annual after-tax profit of 27.8969 million yuan; According to the evaluation report, the World pharmaceutical Evaluation of the total equity of shareholders is 364 million yuan. Data show that the predecessor Department of the World Pharmaceutical Industry was established in 1956, Kaifeng Chinese Medicine Pharmaceutical Factory, March 1997 restructured into Henan Tiandi Pharmaceutical Co., Ltd. The company produces injections, tablets, pills, powder, capsules, tincture and other dosage forms, more than 90 varieties. Leading products have xingnaojing injection, patchouli healthy water, Shaolin bone-setting essence, brain-healthy tablets, Liuwei Dihuang pill, Crown Heart Su-wan and so on.　　Which xingnaojing injection, for the state medical Insurance category B, in the hospital prescription Chinese Medicine market brain drugs market share ranked second. According to the bulletin, the current tasly listed varieties and in the research varieties, stroke, first aid medication only injection of Salvia miltiorrhiza polyphenol acid a product. Through the acquisition of Heaven and earth Medicine to introduce xingnaojing injection, in line with the company's major varieties, large disease species strategy, enrich and supplement the company's heart and brain products product line of the product category, better play the synergistic effect of multiple products.